Table 9 Clinical Characteristics of TRIB1 rs17321515 A allele Carriers and Non-carriers in the NAFLD+CHD Patients

Male/Female

50/44

30/30

χ² = 0.149

Age, y

63.34 ± 10.53

66.58 ± 10.92

t = −1.837

BMI, kg/m²

25.54 ± 3.24

25.35 ± 3.21

t = 0.344

ALT, U/L

23.72 (17.16, 37.60)

23.30 (14.58, 32.86)

Z = − 1.106

AST, U/L

21.72 (17.37, 32.15)

20.12 (15.67, 32.54)

Z = −0.728

GGT, U/L

32.39 (22.76, 44.39)

29.28 (19.67, 40.77)

Z = −1.384

ALP, U/L

80.61 (65.89, 98.21)

76.27 (62.27, 89.86)

Z = −0.947

TG, mmol/L

1.70 (1.31, 2.21)

1.40 (1.00, 2.09)

Z = −1.932

TC, mmol/L

4.66 (3.73, 5.67)

4.54 (3.75, 5.34)

Z = −0.943

HDL, mmol/L

1.04 (0.92, 1.17)

0.95 (0.82, 1.08)

Z = −2.435

LDL, mmol/L

2.80 (2.08, 3.46)

2.88 (2.03, 3.33)

Z = −0.369

TBIL, umol/L

13.30 (9.70, 17.07)

12.48 (9.42, 16.48)

Z = −0.513

FPG, mmol/L

5.64 (4.65, 7.16)

5.79 (4.67, 6.87)

Z = −0.371